Compare ALEC & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALEC | GGZ |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.2M | 112.4M |
| IPO Year | 2019 | N/A |
| Metric | ALEC | GGZ |
|---|---|---|
| Price | $1.45 | $14.34 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 12.8K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.75 |
| Revenue | ★ $69,048,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $160.66 | N/A |
| P/E Ratio | ★ N/A | $6.79 |
| Revenue Growth | ★ 12.26 | N/A |
| 52 Week Low | $0.87 | $9.43 |
| 52 Week High | $3.40 | $12.50 |
| Indicator | ALEC | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 66.98 |
| Support Level | $1.18 | $14.26 |
| Resistance Level | $1.39 | $14.35 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 82.22 | 97.29 |
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.